Ο γενετικός κίνδυνος για διαταραχή μετατραυματικού στρες μπορεί να εξαρτάται από το τραύμα που βιώθηκε [μελέτη]

Before the genetic information stored in DNA can be used to direct cell growth and metabolism, it has to be transferred into RNA. Messenger RNAs (mRNAs) that code for proteins and noncoding RNAs are key components in the transmission of genetic information in all life forms – from viruses to complex mammalian organisms.Following the great success of the 2024 edition of this long-standing symposium, we are looking forward to returning in 2026, bringing together leaders in the RNA field, post-docs and students, with the aim of disseminating and discussing the most recent findings. The programme will include topics on transcription, RNA processing and modification, mRNA export and localisation, mRNA surveillance and decay, translation, the activity of non-coding RNAs, the control of mRNA expression, and coupling among these processes.

This Brain Tumour delineation workshop is aimed at all students, physician assistants, researchers and junior to experienced radiation oncologists who want to hold their institutional brain tumour delineation guideline against the currently available literature, enabling even senior specialists to refresh and validate their knowledge and skills in this field. The workshop brings the live delineation workshops from the annual ESTRO conference to your doorstep in two sessions in which you can practice, learn and are free to ask any questions you might have on this subject.The increasing use of highly conformal radiotherapy techniques, such as VMAT and proton therapy in the treatment of brain tumours, allows us to selectively spare organs at risk while maintaining adequate target coverage. While long-term side effects associated with cranial irradiation have long been recognized, the relationship between toxicity and dose remains complex. Accurate and consistent delineation is therefore essential in modern brain tumour radiotherapy.Standardization of delineation is crucial if we want to advance our knowledge and improve clinical practice in brain tumour radiotherapy. In this course we will focus on practical aspects of brain tumour delineation. A practical toolbox for delineation relevant to daily clinical practice will be provided.

Labroots is pleased to announce the 2nd annual event in the Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Therapy planning committee will invite speakers from industry and academia to discuss key challenges, new opportunities, and recent successes in the current landscape of Cell & Gene Therapy.The 2026 Cell & Gene Therapy Event will serve as a platform for experts in the field to delve into the latest medical advancements utilizing genetics and cellular techniques. Topics covered will encompass cutting-edge therapies like CAR-T cell therapy, CRISPR gene editing, clinical trial updates, and regulatory considerations. The event will comprehensively explore disease applications, spanning from cancer to genetic disorders, while also addressing ethical and societal impacts.